The effect of Trimetazidine and Diazoxide on immunomodulatory activity of human embryonic stem cell-derived mesenchymal stem cell secretome

被引:9
|
作者
Jahandideh, Saeed [1 ]
Maghsood, Faezeh [1 ]
Ghahhari, Nastaran Mohammadi [1 ]
Lotfinia, Majid [1 ]
Mohammadi, Mohammad [2 ]
Johari, Behrooz [1 ]
Kadivar, Mehdi [1 ]
机构
[1] Pasteur Inst Iran, Dept Biochem, Pasteur Ave,POB 1316943551, Tehran, Iran
[2] Shahid Chamran Univ, Basic Sci Fac, Dept Biol, Ahvaz, Iran
来源
TISSUE & CELL | 2017年 / 49卷 / 05期
关键词
Embryonic stem cell-derived mesenchymal stem cells; Secretome; Preconditioning; Trimetazidine; Diazoxide; HEPATOCYTE GROWTH-FACTOR; INFARCTED HEART; STROMAL CELLS; FACTOR-ALPHA; HYPOXIA; INJURY; INTERLEUKIN-10; ACTIVATION; EXPRESSION; DERIVATION;
D O I
10.1016/j.tice.2017.08.003
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Comprehensive proteome profiling of the factors secreted by mesenchymal stem cells (MSCs), referred to as secretome, revealed that it consists of cytokines, chemokines, growth factors, extracellular matrix proteins, and components of regeneration, vascularization, and hematopoiesis pathways. Harnessing this MSC secretome for therapeutic applications requires the optimization of production of secretary molecules. A variety of preconditioning methods have been introduced, which subject cells to stimulatory molecules to create the preferred response and stimulate persistent effects. Pharmacological preconditioning uses small molecules and drugs to increase survival of MSCs after transplantation or prolong release of effective secretary factors such as cytokines that improve immune system responses. In this study, we investigated the effect of secretome of human embryonic-derived mesenchymal stem cells (hESC-MSCs) preconditioned with Trimetazidine (TMZ) and Diazoxide (DZ) on immunomodulatory efficiency of these cells in LPS-induced peripheral blood mononuclear cells (PBMCs). PBMCs were isolated from human peripheral blood and treated with concentrated hESC-MSC-derived conditioned medium and then, the secreted levels of IL-10, TNF alpha and IL-1 beta were assessed by ELISA after induction with LPS. The results showed that TMZ and DZ-conditioned medium significantly enhanced immunomodulatory potential of hESC-MSCs by increasing the secretion of IL-10, TNF alpha and IL-1 beta from LPS-induced PBMCs. We also found that hESC-MSCs did not secrete mentioned cytokines prior to or after the preconditioning with TMZ and DZ. In conclusion, our results implied that TMZ and DZ can be used to promote the immunomodulatory effects of hESC-MSC secretome. It is obvious that for applying of these findings in clinical demands, the potency of different pre-conditioned MSCs secretome on immune response needs to be more clarified.
引用
收藏
页码:597 / 602
页数:6
相关论文
共 50 条
  • [1] Human embryonic stem cell-derived mesenchymal stromal cells
    Hematti, Peiman
    [J]. TRANSFUSION, 2011, 51 : 138S - 144S
  • [2] Anti-inflammatory effects of human embryonic stem cell-derived mesenchymal stem cells secretome preconditioned with diazoxide, trimetazidine and MG-132 on LPS-induced systemic inflammation mouse model
    Jahandideh, Saeed
    Khatami, Shohreh
    Far, Ali Eslami
    Kadivar, Mehdi
    [J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 : 1178 - 1187
  • [3] Microenvironment Regulation of Pluripotent Stem Cell-Derived Neural Progenitor Aggregates by Human Mesenchymal Stem Cell Secretome
    Sart, Sebastien
    Liu, Yijun
    Ma, Teng
    Li, Yan
    [J]. TISSUE ENGINEERING PART A, 2014, 20 (19-20) : 2666 - 2679
  • [4] Controversies in therapeutic application of mesenchymal stem cell-derived secretome
    Sipos, Ferenc
    Muzes, Gyorgyi
    [J]. BIOCELL, 2022, 46 (04) : 903 - 906
  • [5] Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells
    Sze, Siu Kwan
    de Kleijn, Dominique P. V.
    Lai, Ruenn Chai
    Tan, Eileen Khia Way
    Zhao, Hui
    Yeo, Keng Suan
    Low, Teck Yew
    Lian, Qizhou
    Lee, Chuen Neng
    Mitchell, Wayne
    El Oakley, Reida Menshawe
    Lim, Sai-Kiang
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2007, 6 (10) : 1680 - 1689
  • [6] Bone formation of embryonic stem cell-derived mesenchymal stem cells
    Jung, Yeon Tae
    Yoo, Ki-Yeon
    Lee, Hee Su
    [J]. TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2015, 12 : 132 - 137
  • [7] Bone formation of embryonic stem cell-derived mesenchymal stem cells
    Yeon Tae Jung
    Ki-Yeon Yoo
    Hee Su Lee
    [J]. Tissue Engineering and Regenerative Medicine, 2015, 12 : 132 - 137
  • [8] Microvascular Mural Cell Functionality of Human Embryonic Stem Cell-Derived Mesenchymal Cells
    Boyd, Nolan L.
    Nunes, Sara S.
    Jokinen, Jenny D.
    Krishnan, Laxminarayanan
    Chen, Yinlu
    Smith, Kristyn H.
    Stice, Steven L.
    Hoying, James B.
    [J]. TISSUE ENGINEERING PART A, 2011, 17 (11-12) : 1537 - 1548
  • [9] Human embryonic stem cell-derived mesenchymal stem cells improved premature ovarian failure
    Bahrehbar, Khadijeh
    Rezazadeh Valojerdi, Mojtaba
    Esfandiari, Fereshteh
    Fathi, Rouhollah
    Hassani, Seyedeh-Nafiseh
    Baharvand, Hossein
    [J]. WORLD JOURNAL OF STEM CELLS, 2020, 12 (08): : 857 - 878
  • [10] The genes involved in asthma with the treatment of human embryonic stem cell-derived mesenchymal stem cells
    Lin, Yong-Dong
    Fan, Xing-Liang
    Zhang, Hong
    Fang, Shu-Bin
    Li, Cheng-Lin
    Deng, Meng-Xia
    Qin, Zi-Li
    Peng, Ya-Qi
    Zhang, Hong-Yu
    Fu, Qing-Ling
    [J]. MOLECULAR IMMUNOLOGY, 2018, 95 : 47 - 55